Skip to main content
TNDM logo

TNDM · Tandem Diabetes Care Inc · Analyst Estimates

Track TNDM — free
$16.31 -0.26 (-1.57%) At close · Sep 30
Market Cap
$1.09B
Shares
69.58M
Volume · Sep 30 2.2M Avg daily vol (3M) 1.93M

Analyst Estimates

Compare analyst forecasts for Tandem Diabetes Care Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-24 23:47 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.91
-0.66907
-0.4541
—
-0.66707
-0.69204
-0.66707
-0.70667
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
7
0
11
1
Revenue
USD
Publication date not stated
1063753000
1072364370
1081600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
24
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.3
0.1677
0.57
—
0.1707
0.11377
0.1707
0.07778
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
4
0
12
1
Revenue
USD
Publication date not stated
1165464640
1205147270
1277300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
24
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.36
-0.24226
-0.16384
—
-0.24226
-0.18945
-0.24226
-0.19781
— — — —
EPS
analysts
Publication date not stated
— — —
19
— — — —
12
14
3
3
Revenue
USD
Publication date not stated
263000000
266045230
273900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
22
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.02
0.17609
0.32
—
0.1782
0.13343
0.1782
0.13158
— — — —
EPS
analysts
Publication date not stated
— — —
19
— — — —
5
4
12
14
Revenue
USD
Publication date not stated
292274000
304098620
315000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
22
— — — — — — — —
Key facts CIK 1438133 CUSIP 875372203 13F (30d) 14 filings 8 filers Visit website Investor relations